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Abstract
In the present work, we report two cases of monozygotic twins who developed prolonged apnea during
electroconvulsive therapy (ECT) as a complication of anesthesia. In both cases, prolonged action of succinylcholine
caused by a butyrylcholinesterase (BCHE) deficiency was confirmed by means of the dibucaine number test. In
both cases, genetic analysis using the polymerase chain reaction revealed haplotype combined A and K variant
mutations of the BCHE gene, both in the heterozygous form. These data show the potential risk of BCHE
deficiency as a complication of anesthesia during ECT, and in particular underline the possible genetic contribution
within a complex pathogenetic model.
Introduction
Electroconvulsive therapy (ECT) is considered to be the
most powerful antidepressant intervention, and is thus
recommended for the treatment of severe pharmacore-
fractory major depressive disorder (MDD) according to
international guidelines. Moreover, ECT is usually well
tolerated and the potential risks are mainly limited to
anesthesia [1]. With regard to muscle relaxation during
ECT, several reports of prolonged apnea due to the
extended action of depolarizing neuromuscular blocking
agents have been published of late [2-5].
Reduction of butyrylcholinesterase (BCHE) activity, as
first described by German physician W Karow [6,7], can
be induced by several somatic diseases, drugs such as
acetylcholinesterase inhibitors, steroids, some antide-
pressants, oral contraceptives and organophosphate poi-
soning [4,8,9]. Also, inherited forms of BCHE deficiency
are known [7], and affect up to 25% of the Caucasian
population [5]. Mutations of the butyrylcholinesterase
gene (BCHE; 3q26.1-3q26.2, OMIM 177400) were sus-
pected in patients who experienced prolonged apnea
after application of several neuromuscular blocking
agents. The most common A (Asp70Gly) and K
(Ala536Thr) variants were recently detected in patients
with prolonged apnea during ECT [5].
Here, we report two cases of monozygotic twins, who
both underwent ECT because of treatment-refractory
severe major depressive episodes. Both patients showed
prolonged apnea during anesthesia.
Case presentation
Patient 1
A 55-year-old, married male clerk was admitted for ECT
in December 2006 because of medication-resistant psy-
chotic depression according to Diagnostic and Statistical
Manual of Mental Disorders, fourth edition (DSM-IV)
criteria. After antidepressant medication was tapered off,
ECT was delivered three times a week. Right unilateral
(RUL) stimulation was administered using a Thymatron
IV ECT apparatus (Somatics Inc., Lake Buff, IL, USA).
During the first ECT, general anesthesia was carried out
with thiopental; for muscle relaxation succinylcholine
was given. During awakening prolonged apnea was
observed for about 25 min and mask ventilation was
required. Since BCHE deficiency was suspected, a dibu-
caine number test was carried out that showed an inhi-
bition rate of 53% (normal range > 70%). A dose
reduction of succinylcholine, switch to cisatracurium
and prolonged mask ventilation allowed the continua-
tion of ECT, which led to a full recovery (diagnosed on
follow-up April 2011).
Patient 2
A 58-year-old single weaver, the monozygotic twin of
patient 1, was transferred to our hospital 2.5 years after
our first patient’s presentation because of severe MDD
with psychotic features. In his case, his depressive
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symptomatology had already lasted 6 years without any
response to medication. Similar to patient 1, ECT was
chosen as treatment and anesthesia was carried out with
etomidate and succinylcholine. After ECT, retarded awa-
kening from anesthesia was observed, which lasted up to
3 h and persisted despite a switch to thiopental or pro-
pofol and a change of muscle relaxant to mivacurium.
Prolonged apnea was observed only once and could be
managed by mask ventilation so that no further changes
were required and ECT could be administered until
clinical remission was achieved. However, analysis of
BCHE activity showed a marked deficiency as revealed
by an inhibition rate of 43% on the dibucaine test. In
this case, as with our first patient, the ECT continuation
led to a stable remission, which had persisted on follow
up in April 2011.
For the genetic analysis, PCR was carried out in both
cases. A part of exon 2 and the whole of exon 4 includ-
ing the adjacent 3’ untranslated region of the BCHE
gene were sequenced double-stranded from genomic
DNA. The sequence alignment was conducted using the
GenBank sequence NM_000055.2. Assessments with
known mutations listed in the Human Gene Mutation
Database (HGMD) revealed a haplotype combination of
A and K variants of the BCHE gene, both in the hetero-
zygous form.
Conclusions
Taken together, these cases show the potential risk of
BCHE deficiency as a complication of anesthesia during
ECT and in particular highlight the genetic component
as a relevant pathogenetic factor apart from somatic and
pharmacological aspects. Early identification of inherited
forms of BCHE deficiency seem thus to be especially
important, since during a course of ECT, serial anesthe-
sia is required for treatment. Finally, in view of the high
heritability of major depression, patients with BCHE
deficiency might also be informed since ECT might also
be considered for treatment in other family members.
Consent
Written informed consent was obtained from both
patients for publication of this case report.
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